Integrum (INTEG B.ST) Stock Price

Integrum Price

OMX·CLOSED
8.62
​
Market closed

Revenue has compounded at 24.9% per year over the past 9 years to 91.10 M SEK. Integrum's net margin stands at -33.8%, down from -5.0% several years earlier.

Integrum stock price

Access this data via the Eulerpool API

Integrum business model & stock analysis

Integrum AB engages in the manufacturing of medical devices. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2017-05-15. The company provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The firm provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.

Frequently asked questions about Integrum

Converted at the current exchange rate, the Integrum share trades at 0.77 EUR (8.62 SEK).

The Integrum share (INTEG B.ST) is listed on 3 stock exchanges, including: Frankfurt (6Y1.F), Stockholm (INTEG B.ST).

The expected revenue of Integrum is 124.39 M SEK. This figure is based on current financial data and reflects the company's business performance.

The profit cannot currently be calculated for Integrum.

The P/E ratio cannot be calculated for Integrum at the moment.

The price-to-sales ratio (P/S) of Integrum is currently 1.43. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Integrum stock.

The Eulerpool Quality Score for Integrum is 2/10.

The ISIN of Integrum is SE0009807266. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Integrum is A2DSA6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Integrum is INTEG B.ST. The ticker symbol is used to trade Integrum shares on the stock exchange.

Fair ValueTerminal
7.59 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
2.94 M SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website integrum.se
Country
Sweden
Currency
SEK
Initial public offering
May 15, 2017
ISIN
SE0009807266
Cusip
W4R62R103
Market capitalization
224.38 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/Ee 2027
—
P/Ee 2028
—
P/S
P/Se
1.43
EV/EBIT
—
P/B Ratio
1.26
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-16.89 %
Last updated Oct 10, 2026, 2:34 PM

Integrum Peer Group

Integrum Ticker

FRANKFURT · 6Y1.FSTOCKHOLM · INTEG-B.STSTOCKHOLM · INTEG B.ST

Integrum FIGI

INTEGB:SF · BBG00GPW32R9INTEBS:PO · BBG00JL6YM87INTEGSEK:X2 · BBG00JL713Z3INTEGSEK:XB · BBG00JL71409INTEGSEK:XH · BBG00JL71427INTEGSEK:XF · BBG00JL71445INTEGSEK:XE · BBG00JL71463INTEGSEK:XJ · BBG00JL71472INTEGSEK:XL · BBG00JL71481INTEGSEK:XG · BBG00JL71490INTEGSEK:XO · BBG00JL714B7INTEGSEK:XS · BBG00JL714G2

All fundamentals and in-depth analysis of Integrum

Our stock analysis for Integrum stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integrum. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.